Cagrilintide + Retatrutide Quick Start The cagrilintide + retatrutide stack combines two investigational weight-loss peptides
Tirzepatide Tirzepatide is a novel, synthetic peptide engineered to achieve dual agonism of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and GLP-1
In a landmark Phase 2 obesity trial, participants receiving the highest dose achieved: Up to ~24% average weight loss at 48 weeks Weight loss had not yet plateaued at the end of the study Potential for even greater reductions with longer treatment duration For context: Semaglutide (GLP-1): ~15% weight loss Tirzepatide (GIP + GLP-1): ~2123% weight loss Retatrutide (GIP + GLP-1 + Glucagon): ~24%+ weight loss in Phase 2 studies Common side effects were similar to other GLP-1based therapies and included nausea, vomiting, diarrhea, constipation, and abdominal discomfort, primarily during dose escalation
Your doctor should know if you have a history of: Pancreatitis (acute or chronic)both medications carry warnings about pancreatitis risk Severe gastrointestinal disease , including gastroparesis, which may be exacerbated by GLP-1-based therapies Renal impairment sitagliptin requires dose adjustment based on eGFR, while tirzepatide does not require dose adjustment, though caution is advised with dehydration Thyroid disease Mounjaro's UK SmPC notes that rodent studies showed an increased incidence of thyroid C-cell tumours, though the relevance to humans is unknown
Contact Information For questions before or during the process, according to the company's published contact information, Wellorithm offers customer support through the following channels: Phone: (877) 402-6778 Email: [email protected] Hours: 24/7, according to the company's published materials View the current Wellorithm GLP-1 program offer (official Wellorithm page) Summary: What the Program Includes + Key Considerations What the Program Includes Wellorithm's program includes virtual clinician evaluation, access to compounded semaglutide or tirzepatide (if a prescription is issued), personalized weight management planning, medication shipment to the patient's address, 24/7 support access, and a published guarantee with defined eligibility conditions
Participants given the highest dose lost around 20 pounds in 12 weeks, and others lost inches from their waist in 6 months
